These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 39125710)

  • 1. Personalized Assessment for Cancer Prevention, Detection, and Treatment.
    Paleari L
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blueprint for cancer research: Critical gaps and opportunities.
    Elmore LW; Greer SF; Daniels EC; Saxe CC; Melner MH; Krawiec GM; Cance WG; Phelps WC
    CA Cancer J Clin; 2021 Mar; 71(2):107-139. PubMed ID: 33326126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial.
    Baxter G
    Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
    [No Abstract]   [Full Text] [Related]  

  • 4. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing of cancer genomes: lessons learned.
    Corrigan AE; Taylor R; Rallis KS
    Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.
    Vellichirammal NN; Chaturvedi NK; Joshi SS; Coulter DW; Guda C
    Cancer Lett; 2021 Feb; 499():24-38. PubMed ID: 33248210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
    Ciardiello F; Arnold D; Casali PG; Cervantes A; Douillard JY; Eggermont A; Eniu A; McGregor K; Peters S; Piccart M; Popescu R; Van Cutsem E; Zielinski C; Stahel R
    Ann Oncol; 2014 Sep; 25(9):1673-1678. PubMed ID: 24950979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
    Hu DH; Gong P; Ma YF; Cai LT
    Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing approach for identifying hereditary colorectal cancer syndromes.
    Laghi L; Ricciardiello L
    Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer molecular markers: A guide to cancer detection and management.
    Nair M; Sandhu SS; Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear image-guided personalized treatment and prevention of cancers.
    Yang DJ; Kong F; Shen LH; Inoue T; Zakko S
    Curr Med Chem; 2012; 19(20):3253-4. PubMed ID: 22664240
    [No Abstract]   [Full Text] [Related]  

  • 13. Translating Germline Cancer Risk into Precision Prevention.
    Yurgelun MB; Chenevix-Trench G; Lippman SM
    Cell; 2017 Feb; 168(4):566-570. PubMed ID: 28187278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blackboard to Bedside: A Mathematical Modeling Bottom-Up Approach Toward Personalized Cancer Treatments.
    Hamis S; Powathil GG; Chaplain MAJ
    JCO Clin Cancer Inform; 2019 Feb; 3():1-11. PubMed ID: 30742485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention.
    Lam KK; Thean LF; Cheah PY
    Int J Biochem Cell Biol; 2021 Aug; 137():106032. PubMed ID: 34182137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry based proteomics and metabolomics in personalized oncology.
    Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor DNA-From bench to bedside.
    Lim JSJ; Janku F; Yap TA
    Curr Probl Cancer; 2017; 41(3):212-221. PubMed ID: 28416241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial. Molecular image-guided cancer treatment: moving towards personalized medicine--Part I.
    Liu Z
    Curr Pharm Biotechnol; 2013; 14(7):643. PubMed ID: 24476455
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.